Results 281 to 290 of about 115,762 (301)

The role of ligand efficiency metrics in drug discovery

Nature Reviews Drug Discovery, 2014
Andrew L Hopkins, Gyorgy M Keseru, Paul D Leeson   +2 more
exaly  

Fas Ligand

2008
openaire   +1 more source

Principles in the design of ligand-targeted cancer therapeutics and imaging agents

Nature Reviews Drug Discovery, 2015
Madduri Srinivasarao, Philip S Low
exaly  

Fas/Fas ligand and tumor immunity

2002
Donata Rimoldi, Jean-Charles Cerottini, Pedro Romero   +2 more
openaire   +1 more source

Community-wide assessment of GPCR structure modelling and ligand docking: GPCR Dock 2008

Nature Reviews Drug Discovery, 2009
Mayako Michino, Charles L Brooks, John Moult   +2 more
exaly  

Ligand-targeted therapeutics in anticancer therapy

Nature Reviews Cancer, 2002
Theresa M Allen
exaly  

The role of Fas ligand in immune privilege

Nature Reviews Molecular Cell Biology, 2001
Douglas R Green
exaly  

Pseudoreceptor models in drug design: bridging ligand- and receptor-based virtual screening

Nature Reviews Drug Discovery, 2008
Gisbert Schneider
exaly  

Ligand-Targeted Drug Delivery

Chemical Reviews, 2017
Madduri Srinivasarao, Philip S Low
exaly  

Computational Ligand Descriptors for Catalyst Design

Chemical Reviews, 2019
Derek J Durand, Natalie Fey
exaly